Sort   by:  
 Page size 
UnknownImpact of HCV Eradication on Lipid Metabolism in HIV/HCV Coinfected Patients: Data from ICONA and HepaICONA Foundation Cohort Study.
Not available
S-EPMC8310285 | biostudies-literature
UnknownDeterminants of loss to care and risk of clinical progression in PLWH who are re-engaged in care after a temporary loss.
Not available
S-EPMC8099893 | biostudies-literature
UnknownSarilumab plus standard of care vs standard of care for the treatment of severe COVID-19: a phase 3, randomized, open-labeled, multi-center study (ESCAPE study).
Not available
S-EPMC9999914 | biostudies-literature
UnknownProtective Role of a TMPRSS2 Variant on Severe COVID-19 Outcome in Young Males and Elderly Women.
Not available
S-EPMC8073081 | biostudies-literature
UnknownRivaroxaban treatment for six weeks versus three months in patients with symptomatic isolated distal deep vein thrombosis: randomised controlled trial.
Not available
S-EPMC9682494 | biostudies-literature
UnknownProjections of non-communicable disease and health care costs among HIV-positive persons in Italy and the U.S.A.: A modelling study.
Not available
S-EPMC5653300 | biostudies-literature
UnknownIncidence and factors associated with the risk of sexually transmitted diseases in HIV-infected people seen for care in Italy: data from the Icona Foundation cohort.
Not available
S-EPMC4682467 | biostudies-literature
UnknownCancer incidence in people with HIV in Italy: Comparison of the ICONA COHORT with general population data.
Not available
S-EPMC12280848 | biostudies-literature
UnknownLongitudinal analysis of HIV-1 coreceptor tropism by single and triplicate HIV-1 RNA and DNA sequencing in patients undergoing successful first-line antiretroviral therapy.
Not available
S-EPMC3954119 | biostudies-literature
UnknownHuman Immunodeficiency Virus Continuum of Care in 11 European Union Countries at the End of 2016 Overall and by Key Population: Have We Made Progress?
Not available
S-EPMC7778352 | biostudies-literature
Sort   by:  
 Page size